Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
155.6 USD | -0.80% | +26.08% | +61.47% |
06-26 | Monetary policy is getting even more confusing | |
06-26 | Citigroup Downgrades Sarepta Therapeutics to Neutral From Buy, Raises Price Target to $176 From $172 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.47% | 14.83B | |
+16.84% | 122B | |
+19.99% | 115B | |
+21.22% | 26.64B | |
-23.40% | 19.91B | |
-17.47% | 16.32B | |
-45.95% | 15.52B | |
-18.88% | 15.49B | |
+3.53% | 13.67B | |
+119.07% | 11.12B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Top Premarket Gainers